Search Results 1641-1650 of 18453 for Immunode

1. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   Known Human Immunodeficiency Virus (HIV) infection. Second malignancy within the previous 3 years, except treated basal cell or localized squamous skin ...

2. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Known positivity for Human Immunodeficiency Virus (HIV). E 09. Unresolved toxicities from prior anticancer therapy, defined as not having resolved to CTCAE ...

3. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

   Human immunodeficiency virus (HIV) infection positive subjects. Hepatitis B virus (HBV) or hepatitis C virus (HCV) infection as indicated by positive ...

4. A Study to Evaluate the Safety and Tolerability of DCC-2618 in Patients with Advanced Malignancies - Mayo Clinic

   Known human immunodeficiency virus or hepatitis C infection only if the patient is taking medications that are described in Section 5.8.2.2, active ...

5. Cobicistat (oral route) - Side effects & dosage - Mayo Clinic

   Cobicistat is used to increase the effects of atazanavir or darunavir for the treatment of human immunodeficiency virus (HIV) infection. HIV is the virus ...

6. Efficacy, Safety, And Tolerability Study Of Lunsekimig Compared With Placebo In Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized By An Eosinophilic Phenotype PERSEPHONE - Mayo Clinic

   History of human immunodeficiency virus (HIV) infection or positive HIV Type 1 (HIV-1)/HIV Type 2 (HIV-2) serology or positive HIV deoxyribonucleic acid ...

7. Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer - Mayo Clinic

   Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this ...

8. A Study of Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for Relapsed Multiple Myeloma - Mayo Clinic

   Known to be human immunodeficiency virus (HIV) positive known or suspected active hepatitis C infection or seropositive for hepatitis B (defined by a ...

9. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   Must be Human Immunodeficiency Virus (HIV) negative. Have adequate organ function without growth factor and/or transfusion support within ≤ 2 weeks prior ...

10. Anaphylaxis - Doctors and departments - Mayo Clinic

    Pediatrician. Phoenix, AZ. Areas of focus: Immunotherapy, Asthma, Food allergy, Drug allergy, Eosinophilic esophagitis, Allergy, Primary immunodeficiency, ...